{
  "identification": {
    "trialId": "METC 03",
    "open": true,
    "acronym": "NO-SEE797ES",
    "title": "Phase I trial for development of NO-SEE797ES, a specific inhibitor for EGFR with C797 mutations but not C797S in solid tumors",
    "nctId": "NCT00000003",
    "phase": "1",
    "locations": []
  },
  "generalEligibility": [
    {
      "references": [
        "I-01"
      ],
      "function": {
        "rule": "IS_AT_LEAST_X_YEARS_OLD",
        "parameters": [
          "18"
        ]
      }
    },
    {
      "references": [
        "I-02"
      ],
      "function": {
        "rule": "OR",
        "parameters": [
          {
            "rule": "HAS_LOCALLY_ADVANCED_CANCER",
            "parameters": []
          },
          {
            "rule": "HAS_METASTATIC_CANCER",
            "parameters": []
          }
        ]
      }
    },
    {
      "references": [
        "I-03"
      ],
      "function": {
        "rule": "AND",
        "parameters": [
          {
            "rule": "MUTATION_IN_GENE_X_IN_ANY_CODONS_Y",
            "parameters": [
              "EGFR",
              "C797"
            ]
          },
          {
            "rule": "NOT",
            "parameters": [
              {
                "rule": "MUTATION_IN_GENE_X_OF_ANY_PROTEIN_IMPACTS_Y",
                "parameters": [
                  "EGFR",
                  "C797S"
                ]
              }
            ]
          }
        ]
      }
    }
  ],
  "cohorts": [
    {
      "metadata": {
        "cohortId": "A",
        "evaluable": true,
        "open": true,
        "slotsAvailable": true,
        "ignore": false,
        "description": "Dose escalation - monotherapy"
      },
      "eligibility": [
      ]
    }
  ]
}